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In order to develop a novel method of visualizing possible Ca2+ signaling during the early differentiation of hESCs into cardi-
omyocytes and avoid some of the inherent problems associated with using fluorescent reporters, we expressed the biolumines-
cent Ca2+ reporter, apo-aequorin, in HES2 cells and then reconstituted active holo-aequorin by incubation with f-coelenterazine. 
The temporal nature of the Ca2+ signals generated by the holo-f-aequorin-expressing HES2 cells during the earliest stages of 
differentiation into cardiomyocytes was then investigated. Our data show that no endogenous Ca2+ transients (generated by re-
lease from intracellular stores) were detected in 1–12-day-old cardiospheres but transients were generated in cardiospheres 
following stimulation with KCl or CaCl2, indicating that holo-f-aequorin was functional in these cells. Furthermore, following 
the addition of exogenous ATP, an inositol trisphosphate receptor (IP3R) agonist, small Ca
2+ transients were generated from day 
1 onward. That ATP was inducing Ca2+ release from functional IP3Rs was demonstrated by treatment with 2-APB, a known IP3R 
antagonist. In contrast, following treatment with caffeine, a ryanodine receptor (RyR) agonist, a minimal Ca2+ response was 
observed at day 8 of differentiation only. Thus, our data indicate that unlike RyRs, IP3Rs are present and continually functional 
at these early stages of cardiomyocyte differentiation. 
Ca2+ signaling, apo-aequorin expression, bioluminescence, HES2 human embryonic stem cells, hESC-derived cardio-
spheres, IP3 and ryanodine receptors 
 
Citation:  Chan, H.Y.S., Cheung, M.C., Gao, Y., Miller, A.L., and Webb, S.E. (2016). Expression and reconstitution of the bioluminescent Ca2+ reporter ae-
quorin in human embryonic stem cells, and exploration of the presence of functional IP3 and ryanodine receptors during the early stages of their dif-
ferentiation into cardiomyocytes. Sci China Life Sci 59, 811–824. doi: 10.1007/s11427-016-5094-6 
 
 
 
INTRODUCTION 
It has long been known that Ca2+ signaling plays a key role 
in many aspects of embryonic development (Jaffe, 1999; 
Berridge et al., 2000; Webb and Miller, 2003; Whitaker, 
2006, Webb et al., 2011; Rosenberg and Spitzer, 2011), as 
well as controlling a wide variety of cellular functions 
(Szent-Györgyi, 1975; Berridge, 1993; Peterson et al., 1994; 
Bootman and Lipp, 2001; West et al., 2001). Indeed, 
well-defined Ca2+ signals have been demonstrated to corre-
late with, and sometimes to directly initiate and/or regulate, 
distinct morphological events (Homa et al., 1993; Swann et 
al., 1994; Chang and Meng, 1995; Webb et al., 1997; Leung 
et al., 1998; Créton et al., 2000; Porter et al., 2003; Ma et 
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al., 2009; Lohmann, 2009; Cheung et al., 2011). In addition, 
when errors occur in the normal pattern of Ca2+ signaling, 
these might result in the onset of a particular disorder or 
disease (Somlo and Erlich, 2001; Splawski et al., 2004; Al-
len et al., 2010; Woods and Padmanabhan, 2012). 
The essential role of Ca2+ in the contraction of the mature 
heart was first identified over a century ago (Ringer, 1883). 
This process, called “excitation-contraction” coupling, is 
now known to be a highly complex mechanism involving a 
number of tightly-coupled ion channels and transporters that 
regulate Ca2+ entry from (and exit to) the extracellular en-
vironment as well as Ca2+ release from (and uptake into) 
intracellular stores such as the sarcoplasmic reticulum (SR). 
This highly regulated process has long been known to in-
volve L-type Ca2+ channels and the Na+/Ca2+ exchanger 
(NCX) in the plasma membrane, and ryanodine receptors 
(RyRs) and the sarco/endoplasmic reticulum Ca2+ ATPase 
(SERCA) in the SR (reviewed by Bers, 2002; Seidler et al., 
2007; Zhao et al., 2015). More recently, Ca2+ release via 
inositol 1,4,5-trisphosphate receptors (IP3Rs) in the SR, and 
via the two pore channel 2 (TPC2) in lysosomes, Ca2+ ex-
trusion via the plasma membrane Ca2+ ATPase (PMCA), 
Ca2+ uptake into and release from mitochondria via a Ca2+ 
uniporter and mitochondrial NCX, and modulation of Ca2+ 
via sympathetic activation have been identified to play a 
role in normal heart function (Bers, 2002; Hund et al., 2008; 
Griffiths, 2009; Mohamed et al., 2010; Capel et al., 2015; 
Nita et al., 2015). Thus, we now know that the precise level 
of Ca2+ is maintained via the complex interaction between a 
range of different Ca2+ channels and receptors located in 
various organelles as well as in the plasma membrane. If 
this tight control of the intracellular Ca2+ concentration is 
lost then the cells undergo necrosis or apoptosis, which can 
lead to myocardial infarction and heart failure (Schaper et 
al., 1999; Gill et al., 2002; Lim et al., 2007; Konstantinidis 
et al., 2012; Fischer et al., 2013).  
As well as regulating mature heart function via excita-
tion-contraction coupling (Bers, 2002; Seidler et al., 2007; 
Greenstein and Winslow, 2011), Ca2+ signaling has also 
been shown to play a role in heart development (Pucéat and 
Jaconi, 2005), via various different pathways and mecha-
nisms, termed “excitation-transcription” coupling (Wu et 
al., 2006; Seidler et al., 2007). In zebrafish embryos, for 
example, a series of Ca2+ transients were observed to be 
generated in the region of the developing heart; these tran-
sients were generated every 10–20 min and the Ca2+ con-
centration was elevated 10-fold higher than the normal 
background level of Ca2+ (Créton et al., 1998). In addition, 
when embryos were treated with a Ca2+ buffer, BAPTA, one 
of the most obvious effects was the development of a defec-
tive heart; even though a distinct atrium and ventricle were 
still formed, the heart was smaller than normal and was not 
capable of pumping blood (Créton et al., 1998). In the 
chick, when embryos were treated with ouabain or ionomy-
cin to increase the intracellular Ca2+ either indirectly (via 
the NCX) or directly, respectively, differentiation of the 
cells in the posterior areas of the heart-forming region was 
blocked (Linask et al., 2001). In addition, treatment with 
KB-R7943, an NCX inhibitor, affected the early develop-
ment of the heart and blocked the initial heart beats in the 
chick embryo (Linask et al., 2001). Ca2+ signaling also 
plays a key role in heart development in mammals. For 
example, when mouse embryos were cultured with nifedi-
pine or verapamil (both L-type Ca2+ channel blockers), they 
developed hearts with an enlarged left ventricle, no right 
ventricle, a longer and thinner than normal outflow tract and 
abnormal cardiac looping (Porter et al., 2003). Nifedipine 
treatment also affected the expression of some but not all 
the cardiac genes, thus supporting the excitation-transcrip- 
tion model. 
In addition to the research conducted with intact animal 
models, many more reports describe the role of Ca2+ signal-
ing in developing and differentiating cardiomyocytes cul-
tured in vitro (Sauer et al., 2001; Dolnikov et al., 2005; 
Janowski et al., 2006; Fu et al., 2006; Liu et al., 2007, and 
reviewed in Bers, 2008, Lee and Siu, 2012). One point that 
has become eminently clear, however, is that there is a high 
level of diversity in the characteristics of the Ca2+ signals 
generated and thus the relative roles of the varying elements 
of the Ca2+ signaling toolbox, when comparing cardiomyo-
cytes isolated from different species (Liu et al., 2002; Galli 
et al., 2006; Janowski et al., 2006; Zhang et al., 2011). 
Thus, although studies with animals have generated a lot of 
useful information regarding the development of the heart 
and the role of Ca2+ signaling in this process, there is still a 
lot to discover about the development and regeneration of 
the human heart with respect to this essential second mes-
senger. Research on human cardiomyocytes has progressed 
rapidly in recent years following the development of meth-
ods to generate cardiomyocytes from embryonic stem cells 
(ESCs) and induced pluripotent stem cells (iPSCs) with the 
long-term strategy being that these cells might be applied in 
a clinical setting to treat heart disease (Krane et al., 2010; 
Kong et al., 2010; Poon et al., 2011). 
In the majority of studies conducted so far to investigate 
the Ca2+ handling properties of human stem cells or cardi-
omyocytes derived from stem cells, intracellular Ca2+ sig-
nals have been visualized using various fluorescent Ca2+ 
indicators. In the case of reporters such as Fluo-3 (Lee et al., 
2011), Fluo-4 (Satin et al., 2008; Apáti et al., 2013), and 
Fura-2 (Dolnikov et al., 2006; Liu et al., 2007), cells were 
loaded with the dye via incubation with the respective ace-
toxymethyl (AM) ester. However, the problems of using 
such dyes for measuring Ca2+ signals inside cells with re-
gards to the uneven distribution of the dye both within sin-
gle cells via reporter compartmentalization and in beating 
clusters of cells, have been emphasized for both hESCs and 
hESC-CMs (Apáti et al., 2012, 2013). Most recently, the 
development of stem cell-derived cardiomyocytes that sta-
bly express genetically encoded fluorescent Ca2+ reporters 
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based on GCaMP has been described. These include the 
stable expression of: GCaMP3 in H7 hESCs (Shiba et al., 
2012); GCaMP2 in HUES9 hESCs (Apáti et al., 2013); and 
GCaMP6f in induced-pluripotent stem cells (Maddah et al., 
2015). Being genetically expressed, these fluorescent re-
porters do not have the loading issues of some of the fluo-
rescent dyes such as Fluo-4 (Apáti et al., 2013). In addition, 
at least one of the GCaMP variants has been demonstrated 
to be able to detect Ca2+ transients in long-term imaging 
experiments that were conducted over several months (Tian 
et al., 2009). However, genetically encoded fluorescent Ca2+ 
reporters do have some drawbacks when compared with 
synthetic reporters with regards to their signal-to-noise ratio 
and photostability. Regarding the latter, the protein stability 
of GCaMP reporters has been reported to be low (Tian et 
al., 2009). 
Bioluminescent Ca2+ reporters such as aequorin provide 
an alternative means of measuring Ca2+ inside cells, either 
in the cytosol or within specific compartments via targeting 
(Rizzuto et al., 1992). Indeed, bioluminescent Ca2+ reporters 
have a number of advantages over fluorescent Ca2+ report-
ers. For example, in the presence of Ca2+, light is generated 
without the need for excitation and so the autofluorescence, 
photobleaching and photo-toxicity that can be problematic 
with fluorescent reporters (especially during long-term im-
aging) are not an issue with bioluminescent reporters (Mil-
ler et al., 1994). In addition, aequorin has, over the years, 
been shown to be non-disturbing and therefore it does not 
affect the normal development of embryos or the function 
of cells (Miller et al., 1994; Silver, 1996). It is suggested, 
therefore, that likewise, it will not affect the normal prolif-
eration and differentiation of ESCs. Finally, aequorin has a 
wide dynamic range such that it can be used to measure 
changes in free cytosolic Ca2+ between 0.1 to 100 µmol L1, 
and it exhibits a high level of inherent contrast enhancement 
such that the level of luminescence generated is approxi-
mately proportional to the square of the free [Ca2+] 
(Shimomura and Inouye, 1996). Together, these various 
characteristics of bioluminescent Ca2+ reporters such as ae-
quorin allow the ready detection and/or visualization of 
even the smallest changes in intracellular [Ca2+] continually 
over the relatively long time periods that are required to 
monitor ESC differentiation. Aequorin has long been the 
method of choice for recording Ca2+ signals in large cells 
such as muscle fibers and axons (Ridgway and Ashley, 
1967; Baker et al., 1971), and in eggs and early embryos of 
fish, frogs and sea urchins (Ridgway et al., 1977; Eisen and 
Reynolds, 1985; Webb et al., 1997; Leclerc et al., 2000), 
which can be loaded with the reporter via microinjection. 
However, the protein component of aequorin (i.e., 
apo-aequorin) can also be genetically introduced into cells, 
after which active holo-aequorin is reconstituted in vivo by 
simple incubation with its prosthetic co-factor, coelentera-
zine (Rizzuto et al., 1992). The first demonstration of 
apo-aequorin being genetically expressed in cells was re-
ported in the early 1990s when the Tex-mex tobacco plant 
(Nicotiana plumbaginifolia) was successfully transformed 
with the protein (Knight et al., 1991). This group went on to 
show that when aequorin was reconstituted in whole plants 
via incubation with coelenterazine, then they could measure 
changes in Ca2+ in response to wind, touch, cold-shock, 
fungal elicitors, and wounding (Knight et al., 1991, 1992, 
1993). Since then, apo-aequorin has been genetically ex-
pressed in a variety of animal and plant species, as well as 
in cells in culture (reviewed in Webb et al., 2010). Howev-
er, whereas apo-aequorin has previously been genetically 
expressed in cardiomyocytes isolated from adult rats (Bell 
et al., 2006), it has not been expressed in human stem 
cell-derived cardiomyocytes before now. 
In this new study, the HES2 human embryonic stem cell 
line was transduced with apo-aequorin. These cells were 
then used to investigate the onset of functionality of the two 
main SR-localized Ca2+ channels (i.e., IP3R and RyR) dur-
ing the earliest stages of cardiomyocyte differentiation. 
Thus, cardiospheres at day 1, 4, 8 and 12 of differentiation 
were incubated with f-coelenterazine to reconstitute active 
holo-f-aequorin (also called f-aequorin). The result of ap-
plying ATP or caffeine on the generation of Ca2+ signals 
was then recorded using a luminometer in order to assess 
whether (and if so, then when), IP3Rs and RyRs, respec-
tively, were functional in these cells.  
RESULTS 
Transduction of HES2 cells with the 
pLV-EF1-tdTomato-T2A-Apoaequorin (ETO-AEQ) 
plasmid 
Figure 1 demonstrates that HES2 cells were successfully 
transduced with the apo-aequorin gene. Figure 1A shows a 
representative image of a cluster of HES2 cells expressing 
tdTomato, and Figure 1B is a Western blot showing the 
expression of apo-aequorin in cells at passages 57 and 59. 
Measuring endogenous Ca2+ signals in 
holo-f-aequorin-expressing cardiospheres 
An investigation was conducted to determine if any endog-
enous Ca2+ signals could be detected in the holo-f-aequorin 
expressing cells via release from the major intracellular 
Ca2+ store in heart muscle cells, i.e., the SR (Figure 3A). 
Thus, cardiospheres at day 8 of differentiation (Figure 2A) 
were incubated in essentially Ca2+-free bathing medium 
(i.e., Ca2+-free phosphate buffer saline (PBS) with 5 mol 
L1 EGTA) for 160 min. Our data showed that the lumines-
cence intensity remained at a basal level of ~580 counts per 
second (cps) for the duration of the Ca2+ measurements and 
no intracellular Ca2+ transients were detected over this time 
period. At the end of the experiment, 5% Triton X-100  
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Figure 1  HES2 cells that had been transduced with the pLV-EF1- 
tdTomato-T2A-Apoaequorin (ETO-AEQ) lentivirus express both A) 
tdTomato and B) apo-aequorin. A, Expression of tdTomato in a cluster of 
HES2 cells. Scale bar, 20 µm. B, Western blot to show the expression of 
apo-aequorin at two passages of HES2 cells (i.e., P57 and P59). GAPDH 
was used as a loading and membrane transfer control. 
(Figure 2B) was added to the sample to lyse the cardio-
spheres and thus burn-out any remaining unspent ho-
lo-f-aequorin, and this stimulated a ~27-fold increase in 
luminescence intensity (from ~580 cps to ~16,163 cps; Fig-
ure 2B). Thus, even though no endogenous Ca2+ signals 
were recorded from the cardiospheres, there appeared to be 
sufficient active holo-f-aequorin in the cells to generate a 
signal if an endogenous Ca2+ event occurred. 
KCl and CaCl2 stimulate the generation of Ca
2+ signals 
in apo-aequorin-expressing cardiospheres 
Figure 2C and D shows two representative line graphs 
demonstrating the effect of 20 mmol L1 KCl and 1 mmol 
L1 CaCl2 on the holo-f-aequorin-generated biolumines-
cence in cardiospheres at day 8 (Figure 2C) and day 18 
(Figure 2D). In the day 8 cardiospheres (Figure 2C), the 
luminescence intensity increased rapidly by ~0.4-fold (i.e., 
from ~966 cps to ~1,393 cps and from ~852 to ~1,190 cps) 
following each addition of KCl. Three subsequent additions 
of CaCl2 stimulated the luminescence intensity to increase 
by ~0.3 to 0.5-fold (i.e., from ~740 to ~1,093 cps, from 
~596 to ~912 cps, and from ~584 to ~785 cps, respectively). 
During the ~30 min of the luminescence measurements, the 
background level of luminescence also decreased from 
~1,000 to ~525 cps. 
The day 18 cardiospheres (Figure 2D) exhibited a more 
robust response to treatment with both KCl and CaCl2. For 
example, on addition of KCl, the luminescence intensity 
increased by ~1.5-fold (i.e., from ~514 to ~1,273 cps) be-
fore decreasing back to a background level of ~523 cps. The 
two subsequent additions of CaCl2 both resulted in the 
 
 
Figure 2  Representative line graphs to confirm the functionality of holo-f-aequorin in the HES2-derived cardiomyocytes. A, No endogenous Ca2+ signals 
were generated in cardiospheres at day 8 of differentiation. Cardiospheres were incubated with f-coelenterazine for 45 min, after which they were washed 
briefly with PBS and then incubated with PBS containing EGTA for the course of the luminescence intensity measurements. The asterisk indicates a brief 
break (of ~7 min) in the luminescence intensity recording. B, At the end of the Ca2+ measurements, 5% Triton X-100 (black arrow) was added to the cardio-
sphere sample in order to lyse the cells and burn-out any remaining unspent aequorin. C and D, The effect of KCl and CaCl2 on the aequorin-generated lu-
minescence in cardiospheres at (C) day 8 and (D) day 18 of differentiation. Cardiospheres were incubated with f-coelenterazine for 45 min, after which they 
were washed briefly with PBS and then incubated with PBS containing EGTA for the course of the luminescence intensity measurements. KCl (at 20 mmol 
L1) and CaCl2 (at 1 mmol L1) were applied to the cardiosphere samples at the times indicated (see black arrows). 
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Figure 3  Representative line graphs to show the effect of ATP on the aequorin-generated luminescence in cardiospheres at (A) day 1 (n=5), (B) day 4 
(n=4), (C) day 8 (n=3), and (D) day 12 (n=4) of differentiation. Cardiospheres were incubated with f-coelenterazine for 45 min, after which they were 
washed briefly with PBS and then incubated with PBS containing EGTA for the course of the luminescence intensity measurements. At each day of differen-
tiation, 5 µmol L1 ATP was added at three time-points (see black arrows) over a period of ~20 min. On day 12, following the addition of ATP, cells were 
incubated with 50 µmol L1 2-APB after which 5 µmol L1 ATP was again added at three time points. E, Bar chart with mean±SEM fold change in lumines-
cence following the first addition of ATP at day 1 to day 12, and following the first addition of ATP after 2-APB treatment at day 12. Asterisks indicate 
statistically significant results at P<0.05. 
luminescence intensity increasing by ~1.0 to 1.3 fold (i.e., 
from ~523 to ~1,204 cps, and from ~572 to ~1,159 cps after 
the first and second doses, respectively). After each dose of 
CaCl2, the luminescence intensity returned to background 
levels of ~530 and ~542 cps.  
Investigating the effect of ATP on the luminescence 
generated by holo-f-aequorin-expressing cardiospheres 
Figure 3 shows a series of four line graphs, which illustrate 
the effect of ATP on the holo-f-aequorin-generated biolu-
minescence in cardiospheres at day 1, 4, 8, and 12 of dif-
ferentiation. 
At differentiation day 1 (Figure 3A), a small increase in 
the luminescence intensity of ~0.2 fold (i.e., from ~942 to 
~1,129 cps) was recorded following the first dose of ATP. 
However, with the subsequent additions of ATP, no distinct 
increase in luminescence intensity was recorded. In addi-
tion, over the period of 20 min that the experiment was 
conducted, the overall level of luminescence declined from 
~1,080 to ~770 cps.  
At differentiation day 4 and day 8 (Figure 3B and C), 
each of the three applications of ATP stimulated a distinct 
increase in the luminescence intensity generated by the car-
diospheres. In each case, the first dose of ATP produced the 
strongest increase, although this was more obvious in the 
day 4 cardiospheres than in the day 8 cells. Hence, at day 4 
(Figure 3B), the first dose of ATP stimulated ~1 fold in-
crease in the luminescence intensity (i.e., from ~495 to 
~980 cps), whereas the second and third doses only stimu-
lated a ~0.4 fold increase (i.e., from ~554 to ~785 cps, and 
from ~459 to ~638 cps, respectively). Similarly, at day 8 
(Figure 3C), the initial application of ATP stimulated a ~0.3 
fold increase in luminescence intensity (i.e., from ~1,085 to 
~1,445 cps), whereas the subsequent doses both stimulated 
a ~0.2 fold increase (i.e., from ~1,093 to ~1,293 cps, and 
from ~998 to ~1,237 cps, respectively). 
At differentiation day 12 (Figure 3D), each of the three 
applications of ATP generated far more robust increases in 
luminescence intensity than those observed at the earlier 
time points. Thus, after the first, second, and third doses of 
ATP, the luminescence intensity increased by ~2.5, ~1.7 
and ~1.4 fold, respectively (i.e., from ~912 to ~3,264 cps, 
from ~1,264 to ~3,407 cps, and from ~1,234 to ~3,015 cps, 
respectively). Before the first dose of ATP, the background 
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level of luminescence was ~910 cps, then after the first dose 
of ATP, the level of luminescence returned to a background 
level of ~1,270 cps. After the second and third applications 
of ATP, the level of luminescence returned to background 
levels of ~1,280 and ~1,360 cps, respectively. The cardio-
spheres were then incubated with the IP3R antagonist, 
2-aminoethoxydiphenyl borate (2-APB) for ~15–20 min 
after which the cells, still bathed in 2-APB, were stimulated 
with a further two doses of ATP. On addition of 2-APB, the 
level of luminescence declined gradually from ~1,360 to 
~800 cps and then leveled off. The fourth and fifth doses of 
ATP stimulated small increases in luminescence intensity of 
just ~0.6 and ~0.75 fold, respectively (i.e., from ~785 to 
~1,282 cps, and from ~807 to ~1,423 cps, respectively). 
Thus, 2-APB treatment inhibited the normal ATP-    
stimulated increases in luminescence by ~62%. Together, 
these data suggest that at day 1, the cardiospheres exhibited 
a minimal response to 5 µmol L1 ATP, but from day 4 to 
day 12, these cells exhibited an increasing response to such 
ATP treatment.  
Figure 3E shows the mean±SEM fold increase in lumi-
nescence at day 1 to day 12 on stimulation with the first 
dose of ATP, and on day 12 on stimulation with the first 
dose of ATP following 2-APB treatment. The fold increase 
at day 12 was significantly greater (at P<0.05) than that at 
day 1 and day 8. In addition, at day 12, the mean±SEM fold 
increase in luminescence on addition of ATP following 
2-APB treatment was significantly lower (at P<0.05) than 
that before treatment. 
Investigating the effect of caffeine on the luminescence 
generated by apo-aequorin-expressing cardiospheres 
Figure 4 shows a series of five line graphs; the first four 
graphs (Figure 4A–D) show the effect of caffeine on the 
holo-f-aequorin-generated bioluminescence in cardiospheres 
at day 1, 4, 8 and 12 of differentiation, whereas the last 
graph (Figure 4E) shows a holo-f-aequorin “burnout”, 
which was conducted at the end of the day 12 experiment 
shown in Figure 4D. 
 
 
Figure 4  Representative line graphs to show the effect of caffeine on the aequorin-generated luminescence in cardiospheres at (A) day 1 (n=3), (B) day 4 
(n=3), (C) day 8 (n=4), and (D) day 12 (n=3) of differentiation. Cardiospheres were incubated with f-coelenterazine for 45 min, after which they were 
washed briefly with PBS and then incubated with PBS containing EGTA for the course of the luminescence intensity measurements. At each day of differen-
tiation, 50 mmol L1 caffeine was added at three time-points (see black arrows) over a period of ~20 min. The asterisk in panel D indicates a brief break (of 
~1 min) in the luminescence intensity recording. E, Representative (n=3) line graph to show the effect of adding 5% Triton X-100 on the luminescence in-
tensity at the end of Ca2+ recording on Day 12. F, Bar chart with mean±SEM fold change in luminescence following the first addition of caffeine at day 1 to 
day 12. No statistically significant differences were observed amongst the data. 
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At differentiation days 1, 4 and 12 (Figure 4A, B and D), 
the luminescence intensity in the cardiospheres did not 
change following the three additions of caffeine. At day 8 of 
differentiation (Figure 4C), however, small increases in 
luminescence intensity were observed following the addi-
tion of caffeine. The change in luminescence intensity was 
most obvious after the first and second doses of caffeine 
with an increase of ~0.3 fold for both (i.e., from 841 to 
1,128 cps, and from 784 to 985 cps, respectively). The sub-
sequent two doses of caffeine yielded even smaller changes 
in the luminescence intensity. 
Caffeine appeared to exhibit a measurable effect on the 
luminescence generated by cardiospheres at day 8. Howev-
er, it did not have an effect at days 1, 4 or 12. ATP treat-
ment (see Figure 3) did indicate that sufficient ho-
lo-f-aequorin was present in cardiospheres on days 1 and 4, 
and burnout of the caffeine treated cells on day 12 appeared 
to confirm this. Figure 4E is a representative example 
showing the effect of Triton X-100 treatment on the lumi-
nescence generated by the day 12 cardiospheres; the lumi-
nescence intensity was shown to increase by ~12.5 fold (i.e., 
from ~146 to ~1,965 cps). Therefore, we suggest that the 
lack of luminescence observed was a real result and not due 
to an insufficient amount of unspent holo-f-aequorin being 
present in the cells. 
Figure 4F shows the mean±SEM fold increase in lumi-
nescence in cardiospheres at day 1 to day 12 on stimulation 
with the first dose of caffeine. These data show that at day 
1, day 4 and day 12 there were no obvious changes in lumi-
nescence following the addition of caffeine. There was a 
slight increase in luminescence at day 8 but this was not 
significantly different from the data collected on the other 
days. 
DISCUSSION  
Preparation of the apo-aequorin-expressing HES2 cells 
An apo-aequorin-expressing HES2 hESC line was generat-
ed by lentiviral transduction of cells with the ETO-AEQ 
plasmid. Viral transduction methods have been previously 
used to genetically express apo-aequorin in the cytosol, or 
targeted to distinct intracellular organelles, in a variety of 
cell types, including HeLa cells, adrenal medulla chromaf-
fin cells, HEK293 cells, GH3 pituitary cells and PC12 cells 
(Chamero et al., 2002; Missiaen et al., 2004; SantoDomingo 
et al., 2008). In addition, apo-aequorin has previously been 
expressed genetically in cardiomyocytes isolated from adult 
rats (Bell et al., 2006), but this is the first time that the pro-
tein has been expressed in hESCs and in hESC-CMs. The 
HES2 cell line was chosen as it has been previously report-
ed that the vast majority (i.e., over 90%) of cardiomyocytes 
derived from these cells are ventricular in nature (Mummery 
et al., 2003; Weng et al., 2014). These cells were transduced 
with the apo-aequorin plasmid, which also contained the 
coding sequence for tdTomato. This bright red fluorescent 
protein was first described over a decade ago (Shaner et al., 
2004), and it has been used as a marker to allow the rapid 
identification and confirmation of successful transduction 
simply via determining the presence of fluorescence (Sala-
mango et al., 2013). In addition, the EF1 promoter was 
used, as vectors containing a transgene under the control of 
this promoter have been demonstrated to efficiently trans-
duce human ESCs (Ma et al., 2003). The visualization of 
tdTomato fluorescence in our transduced HES2 cells (Fig-
ure 1A) indicated that these cells also expressed the 
apo-aequorin gene. Indeed, the expression of apo-aequorin 
in this cell line was subsequently confirmed via Western 
blot (Figure 1B).  
The functionality of the apo-aequorin expressed in car-
diospheres derived from our transduced HES2 cell line was 
also tested. Holo-f-aequorin was reconstituted in the cardi-
ospheres via incubation for ~45 min with f-coelenterazine, 
after which the level of luminescence generated from these 
cells in essentially Ca2+-free medium (i.e., PBS containing  
5 µmol L1 EGTA) was determined (Figure 2A). No en-
dogenous Ca2+ transients could be detected over the 
160-min duration of the measurements. However, on the 
addition of Triton X-100 at the end of these measurements, 
a considerable amount of aequorin-generated luminescence 
was released from the cardiospheres (Figure 2B). This indi-
cates that there was sufficient functional holo-f-aequorin in 
the cells to be able to detect changes in intracellular Ca2+. In 
addition, distinct intracellular Ca2+ transients were generat-
ed on treatment with KCl and CaCl2 at day 8 and day 18 
(Figure 2C and D). It is well known that KCl can induce 
membrane depolarization in muscle cells, stimulating Ca2+ 
influx via L-type Ca2+ channels (Yanagisawa and Okada, 
1994; Yu et al., 1995), and the addition of Ca2+ can stimu-
late an increase in intracellular Ca2+ via activation of the 
store-operated Ca2+ influx pathway (Apáti et al., 2012). Our 
results confirmed that the apo-aequorin expressing cells, 
when bathed in f-coelenterazine to reconstitute ho-
lo-f-aequorin responded as expected when stimulated by 
treatment with KCl and CaCl2.  
It has been previously shown that human ESCs (HUES9 
cells) loaded with Fluo-4 exhibit a low level of endogenous 
intracellular Ca2+ signaling in both normal Ca2+-containing 
and Ca2+-free medium, and that in cardiomyocytes derived 
from HUES9 cells, Ca2+ transients are generated in sponta-
neously contracting cardiac cells (Apáti et al., 2012, 2013). 
In addition, spontaneous Ca2+ transients were reported in 
20-day-old hESC-CMs derived from H7 and HES3 cells 
(Lee et al., 2011), and in 18–24-day-old HES2-derived CMs 
on electrical stimulation (Liu et al., 2007). Cardiomyocytes 
derived from HES2 cells have been reported to begin con-
tracting spontaneously as early as day 8 of differentiation. 
However, our apo-aequorin expressing HES2-derived car-
diomyocytes were not observed to contract even on day 12 
of differentiation and no spontaneous Ca2+ transients were 
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observed whether the cardiospheres were kept in 
Ca2+-containing (data not shown) or Ca2+-free medium 
(Figure 2A). This indicates a delay in the maturation of  
these cells, which might be due to the expression of apo- 
aequorin and/or tdTomato in these cells. In order to investi-
gate the possible role of Ca2+ release from intracellular 
stores at the earliest stages of differentiation (i.e., from day 
1 to day 12), experiments were performed in the absence of 
Ca2+ in the incubation medium in order to exclude the pos-
sibility of any trans-sarcolemmal Ca2+ influx via voltage- 
gated Ca2+ channels, which has previously been reported to 
occur in these cells (Mummery et al., 2003), or via SOCE 
(Touchberry et al., 2011) and/or receptor-operated Ca2+  
entry (Chien et al., 1990; Inoue et al., 2006). 
Determination of the presence of functional IP3Rs and 
RyRs during the early differentiation of cardiospheres 
The ability of the aequorin-expressing HES2-derived CMs 
to generate Ca2+ transients in response to ATP and caffeine 
was tested to investigate the presence of functional IP3Rs 
and RyRs during the earliest stages of differentiation, i.e., 
days 1 to 12 (Figures 3 and 4). It is well established that in 
undifferentiated mouse ES cells, Ca2+ release from the SR is 
mediated mainly via IP3Rs with little-to-no involvement 
from RyRs (Yanagida et al., 2004; Kapur et al. 2007). In 
addition, in mouse ESC-derived cardiomyocytes, IP3Rs and 
RyRs are both involved in the release of Ca2+ from the SR, 
although the activity of the former decreases and that of the 
latter increases as differentiation progresses (Fu et al., 
2006). In human ESCs, a role for the IP3R is less well es-
tablished although it has been reported that when HUES9 
cells are treated with ATP, a large increase in intracellular 
Ca2+ is generated (Apáti et al., 2012). We demonstrated that 
the cardiospheres derived from HES2 cells expressing  
holo-f-aequorin exhibited a relatively low response to     
5 µmol L1 ATP on days 1 to 8 but showed an increased 
response with regards to an elevated level of luminescence 
intensity at day 12. Use of an IP3R antagonist, 2-APB (Pep-
piatt et al., 2003), to inhibit the ATP-generated Ca2+ transi-
ents confirmed that IP3Rs are indeed functional in the 
HES2-derived CMs at these early stages of differentiation 
(Figure 3). The increase in ATP response between day 8 
and day 12 is somewhat comparable to the results described 
previously, where the expression of IP3R type 2 increased 
between day 9 to day 11 in mouse ESC-CMs (Fu et al., 
2006). Further work needs to be done to investigate if the 
IP3R plays a distinct role in the early differentiation of car-
diomyocytes from ESCs or not. However, our results do 
indicate that IP3Rs are at least present and functional at  
these early stages of cardiomyocyte differentiation. 
In the apo-aequorin expressing cardiospheres, there were 
no responses following the addition of 50 mmol L1 caffeine 
(i.e., a RyR agonist) on days 1, 4 or 12. However, day 8 
cardiospheres did show a small Ca2+ response to this con-
centration of caffeine (Figure 4). The lack of response to 
caffeine on day 12 might have been due to the ho-
lo-f-aequorin having been inactivated, however, the use of 
Triton X-100 at the end of each experiment confirmed that 
sufficient active holo-f-aequorin was being expressed by the 
cells to reveal any distinct signals that were generated. Such 
an overall lack of response to caffeine has previously been 
reported in 45 to 60 day old cardiomyocytes derived from 
H9.2 hESCs (Dolnikov et al., 2005). More recently, caffeine 
was shown to induce Ca2+ release in hES2-derived cardio-
myocytes but only in a sub-population (~38%) of these cells 
when they were at day 18 to 24 (Liu et al., 2007). We 
therefore suggest that the differences that we observed with 
respect to the stimulatory effect of caffeine at day 8, but not 
at day 12, might be likewise due to a small (and potentially 
variable) fraction of cells that respond to caffeine during 
early differentiation; or perhaps due to the transient expres-
sion of functional RyRs around day 8, which is lost by day 
12. Our findings, however, reinforce the previous observa-
tion that RyRs are underdeveloped and largely non-   
functional in the SR of these early differentiated cardiomy-
ocytes (Dolnikov et al., 2005).  
Together, our results suggest a possible sequential ex-
pression of SR-located Ca2+ release channels, where func-
tional IP3Rs appear before functional RyRs. This is con-
sistent with the expression of these two SR-based receptors 
during embryogenesis in animal models, where functional 
IP3Rs have been shown to be expressed in nearly every cell 
in mice and zebrafish embryos from the earliest stages of 
development and expression continues throughout devel-
opment (Rosemblit et al., 1999; Lee et al., 2003; Leung et 
al., 2009; Cheung et al., 2011). On the other hand, function-
al RyRs are not expressed during the early stages of devel-
opment, but they are expressed later on with the differentia-
tion of excitable cells, including cardiac and skeletal mus-
cle, where the receptors are used for specialized cellular 
functions such as cell contraction (Rosemblit et al., 1999; 
Lee et al., 2003; Leung et al., 2009; Cheung et al., 2011). 
Although we demonstrate that IP3Rs are functional from 
day 1 onwards, and that RyRs appear to only be functional 
at day 8, our current data does not tell us the specific role of 
either receptor with respect to early differentiation of HES2 
ESCs. 
In summary, we have demonstrated that HES2 ESCs can 
be transduced with the apo-aequorin gene and that function-
al holo-f-aequorin can be reconstituted in cardiospheres 
derived from these cells when they are incubated with 
f-coelenterazine. In addition, at the earliest stages of differ-
entiation, detectable Ca2+ signals are generated only in car-
diospheres treated with ATP, whereas their response to caf-
feine is minimal. These data indicate that functional IP3Rs 
are expressed in these cells before functional RyRs are. We 
therefore suggest that the continued development and use of 
genetically expressed bioluminescent Ca2+ reporters such as 
apo-aequorin might offer an alternative method to explore 
Ca2+ signaling during ESC differentiation, especially when 
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long-duration Ca2+ recordings (i.e., lasting hours to days) 
are required. 
MATERIALS AND METHODS 
Generation of the recombinant lentiviral vector carrying 
the apo-aequorin gene 
To generate the ETO-AEQ plasmid (Figure 5A), tdTomato 
and the apo-aequorin gene were fused via a T2A fusion se-
quence, and the expression of tdTomato and apo-aequorin 
were driven by the ubiquitously active EF1 promoter. Re-
combinant lentiviruses were produced by the co-transfection 
of HEK293FT cells with lentivirus packaging vectors and 
the vector of interest gene, as previously described 
(Zufferey et al., 1997). In brief, 24 h prior to co- 
transfection, 293FT cells were seeded in poly-D-Lysine- 
coated T175 flasks at a density of 18×106 cells/flask. The 
supernatant containing the lentiviral particles was harvested 
at 48 and 72 h post-transfection and stored at 80°C before 
use. 
Generation and maintenance of the stable 
apo-aequorin-HES2 cell line  
The HES2 (NIH code: ES02; ES Cell International Pte., 
Ltd., Singapore) human embryonic stem cell (hESC) line 
was maintained in feeder- and serum-free conditions in 
 
 
Figure 5  The Ca2+ signals generated during the earliest stages of HES2 cell differentiation into cardiomyocytes were observed with the bioluminescent 
Ca2+ reporter, aequorin. A, HES2 cells were transduced with the pLV-EF1-tdTomato-T2A-Apoaequorin (ETO-AEQ) plasmid. B, Schematic to illustrate the 
lentivirus transduction process used to generate apo-aequorin-expressing HES2 cells. C, Schematic to show the various components of the culture media 
used for the first 16 days of differentiation of HES2 cells to cardiomyocytes; the red arrows indicate the days when the Ca2+ measurements were made, 
(modified from Figure 1A of Weng et al., 2014). D, The aequorin bioluminescence reaction, which occurs when Ca2+ binds to holo-aequorin and light is 
generated at ~470 nm. 
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mTeSR1 (STEMCELL Technologies Inc., Canada) medium 
on Matrigel- (Discovery Labware, Corning, USA) coated 
plates at 37C and 5% CO2 in a humidified normoxic (i.e., 
ambient O2) environment. The tissue culture plates were 
coated with Matrigel (40 g mL1) at 37C for 30 min just 
prior to seeding the cells. For stable lentiviral transduction 
(Figure 5B), the viral supernatant was added to the HES2 
cells at a multiplicity of infection of 10, and then they were 
incubated for 24 h. tdTomato-positive cells were identified 
by epifluorescence with a Nikon AZ-100 microscope and an 
AZ-Plan Apo 5x/0.05 NA (both from Nikon Corporation, 
Japan), with 510–560 nm excitation and 575–590 nm emis-
sion. Visualization of tdTomato fluorescence was consid-
ered to indicate that the cells also expressed apo-aequorin. 
Western blotting 
Apo-aequorin expressing HES2 cells were washed with 
PBS once, and then lysed with ice-cold EBC lysis buffer, 
consisting of 50 mmol L1 Tris-HCl (pH 8.0), 120 mmol L1 
NaCl, 100 mmol L1 NaF, 1 mmol L1 dithiothreitol, 200 
μmol L1 Na3VO4, 150 nmol L1 phenylmethanesulfonyl 
fluoride (PMSF), 0.5% sodium deoxycholate, 0.5% Nonidet 
P-40, 0.1% sodium dodecyl sulfate (SDS), and complete 
protease inhibitor cocktail (Roche Diagnostics GmbH, 
Germany), just prior to homogenization. The cell lysate was 
then homogenized by passing it several times through a 
21-gauge needle, after which it was centrifuged at 13,000 r 
min1 for 10 min at 4°C. The total protein concentration was 
then measured using the Bradford protein assay (Bio-RAD, 
USA). The proteins were diluted with SDS sample loading 
buffer (consisting of 62.5 mmol L1 Tris-HCl, 50% glycer-
ol, 10% SDS, 5% -mercaptoethanol and 300 mol L1 
bromophenol blue; at pH 6.8) to give a concentration of 30 
μg protein per lane, and electrophoresis was conducted with 
an 8% SDS-polyacrylamide gel for ~1.5 h using a Bio-RAD 
Mini-Protean Tetra System and Bio-RAD Power Pac Basic. 
The gel was run for the first 30 min at 80 V, after which the 
voltage was switched to 120 V for an hour. The SDS-  
polyacrylamide gel was then transferred to an Immobilon 
polyvinylidene fluoride (PVDF) membrane (EMD Milli-
pore, Germany), for ~2 h at 100 V, again using the 
Bio-RAD Tetra and Power Pac. The membrane was blocked 
with 5% non-fat milk in TBST (20 mmol L1 Tris at pH 7.6, 
150 mmol L1 NaCl and 0.1% Tween-20), for ~1 h at room 
temperature. It was then incubated with primary antibodies 
against aequorin (ab9096, Abcam, USA; at a dilution of 
1:1,000), and GAPDH (G8795, Sigma-Aldrich Co. LLC., 
USA; at a dilution of 1:5,000), at room temperature for ~2 
h. After washing with TBST for 310 min, the membranes 
were probed with horse radish peroxidase (HRP)-     
conjugated anti-rabbit and anti-mouse secondary antibodies, 
respectively, at room temperature for ~2 h. The membranes 
were then washed again with TBST for 510 min and the 
protein bands were detected via chemiluminescence using a 
Luminata Western HRP substrate (EMD Millipore). 
Directed cardiac differentiation 
hESCs were differentiated into cardiospheres as described 
previously (Weng et al., 2014; Figure 5C). In brief, large 
clusters of undifferentiated hESCs were digested into 
smaller clusters using Accutase (Invitrogen Life Technolo-
gies, USA), and then they were seeded onto Matrigel-coated 
plates at a density of 3×105 cells/10 cm2 in mTeSR1 medi-
um for 4 days until they reached ~80%–90% confluence. 
This was designated as “day 0”. To initiate cardiac differen-
tiation, the hESC clusters were dissociated with Accutase 
into a single-cell suspension. The cells were then plated into 
an ultra-low attachment 6-well plate (Corning, USA), and 
cultured in mTeSR1 medium containing Matrigel (40 μg 
mL1), BMP-4 (1 ng mL1; Invitrogen Life Technologies) 
and Rho kinase (ROCK) inhibitor (10 μmol L1; R&D Sys-
tems, USA), at 37°C under hypoxic (i.e., 5% O2) conditions. 
After 24 h, the culture medium was removed and the cells 
were washed. They were then incubated with fresh medium, 
consisting of StemPro34 SFM (Invitrogen Life Technolo-
gies) containing ascorbic acid (50 μg mL1; Sigma-Aldrich), 
GlutaMAX-1 (2 mmol L1; Invitrogen Life Technologies), 
BMP-4 (10 ng mL1) and human recombinant activin-A (10 
ng mL1; Invitrogen Life Technologies) for 3 days. On day 
4, IWR-1, a Wnt inhibitor (5 μmol L1; Enzo Life Sciences 
Inc., USA), was added, after which the cardiac mesodermal 
cells developed into cell clusters (i.e., cardiospheres). On 
day 8, the cells were transferred to a normoxic (i.e., 21% 
O2) environment and maintained in StemPro34 SFM con-
taining 50 µg mL1 ascorbic acid for subsequent culturing. 
Temporal Ca2+ data acquisition 
Cardiospheres were transferred to a glass culture tube and 
placed in a Titertek-Berthold FB12 Single Tube Luminom-
eter (Berthold Detection Systems GmbH, Germany), linked 
to a desktop computer, and controlled by the FB12 soft-
ware. The entire luminometer was warmed using a fan 
heater (De’Longhi, Italy) to provide temperatures ranging 
between ~27°C to 32°C in the sample tube. Active ho-
lo-aequorin was reconstituted from the apo-aequorin-   
expressing cardiospheres by incubation with f-coelentera- 
zine (NanoLight Technologies, USA) to a final concentra-
tion of 5 μmol L1 in StemPro-34 SFM for 45 min. The car-
diospheres were then washed once with PBS (137 mmol L1 
NaCl, 2.68 mmol L1 KCl, 16 mmol L1 Na2HPO4, 5.2 
mmol L1 NaH2PO4, pH 7.3) for 5 min followed by incuba-
tion with 2 mL PBS containing 5 μmol L1 EGTA (Thermo 
Fisher, USA) for the subsequent holo-f-aequorin biolumi-
nescence measurements (Figure 5D). Data collection was 
paused briefly during the manual addition of f-coelentera- 
zine and the agonists used to determine the presence or ab-
sence of functional IP3R and RyR in the cardiospheres. At 
the end of each data collection experiment, the cardio-
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spheres were lysed by the addition of 200 μL PBS contain-
ing 5% Triton X-100. 
Testing the functionality of reconstituted 
holo-f-aequorin in cardiospheres  
In one set of experiments, after holo-f-aequorin reconstitu-
tion, the background level of luminescence was recorded for 
a period of 160 min. Data acquisition was then paused 
briefly while 200 μL PBS containing 5% Triton X-100 was 
added to the tube containing the cardiospheres and lumi-
nescence recording was resumed. The Triton X-100 was 
used to permeabilize the cardiosphere cells and thus expose 
any unspent holo-f-aequorin to extracellular Ca2+. This con-
firmed that the low level of aequorin-generated lumines-
cence (and thus the [Ca2+]) observed was real and not due to 
the Ca2+ reporter being used up (Leung et al., 2009). 
In another series of experiments, after holo-f-aequorin 
reconstitution, the background level of luminescence was 
recorded for ~1 h, after which data acquisition was paused 
briefly while 200 μL KCl (Sigma-Aldrich; at 20 mmol L1 
in bathing medium) was added to the luminometer tube 
containing the cardiospheres and recording was resumed. 
The effect of KCl on the aequorin-generated luminescence 
was measured for ~5 min, after which in some cases the 
cardiospheres were treated with a second dose of 20 mmol 
L1 KCl. Cardiospheres were also treated with 200 μL 
CaCl2 (Sigma-Aldrich; at 1 mmol L
1 in bathing medium), 
using a similar protocol to that described for the KCl.  
Determination of functional IP3Rs and RyRs in cardio-
spheres 
After holo-f-aequorin reconstitution, the background level 
of luminescence was recorded for ~1 h after which data 
acquisition was paused briefly. In some experiments, 200 
μL ATP (Sigma-Aldrich; at 5 μmol L1 in bathing medium) 
was added to the tube containing the cardiospheres whereas 
in other experiments, 200 μL caffeine solution (Sig-
ma-Aldrich; at 50 mmol L1 in bathing medium) was added 
to the cardiospheres. The effect of ATP or caffeine was 
measured for a few minutes, after which the cardiospheres 
were treated with a second dose of either 5 μmol L1 ATP or 
50 mmol L1 caffeine, and then with a third dose of ATP or 
caffeine being added a few minutes later again. The cardio-
spheres were thus exposed to final [ATP] of 0.45, 0.83 and 
1.15 μmol L1 after the first, second and third applications 
of 5 μmol L1 ATP, respectively, or they were exposed to 
final [caffeine] of 4.5, 8.3 and 11.5 mmol L1 after the first, 
second and third applications of 50 mmol L1 caffeine, re-
spectively. As the day 12 cardiospheres generated a robust 
luminescence response to ATP, they were incubated with 
2-APB (Sigma Aldrich) for ~15–20 min, after which the 
cells were treated with three doses of 5 µmol L1 ATP 
again. 2-APB was prepared as a stock solution of 30 mmol 
L1 in dimethyl sulphoxide, after which ~4.3 µL was added 
to the cardiospheres in the luminometer tube to give a final 
concentration of 50 µmol L1 2-APB. 
Data analysis 
Data were exported to Excel 2013 (Microsoft, USA) for 
graph plotting, and Minitab 17 (State College, USA) was 
used to conduct one-way ANOVA to determine statistically 
significant differences between the data sets.  
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